American Journal of Obstetrics and Gynecology

Journal

Publication Venue For

  • Chronic Hypertension in Pregnancy. 2019
  • Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.  221:513.e1-513.e15. 2019
  • Miscarriage among women in the United States Women's Interagency HIV Study, 1994–2017.  221:347.e1-347.e13. 2019
  • A contemporary amniotic fluid volume chart for the United States: The NICHD Fetal Growth Studies–Singletons.  221:67.e1-67.e12. 2019
  • Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.  221:9-18.e8. 2019
  • Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.  220:265.e1-265.e11. 2019
  • Intrauterine growth discordance across gestation and birthweight discordance in dichorionic twins 2019
  • A conceptual framework for the impact of obesity on risk of cesarean delivery.  219:356-363. 2018
  • Fetal growth velocity: the NICHD fetal growth studies.  219:285.e1-285.e36. 2018
  • Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity.  219:296.e1-296.e8. 2018
  • Reply.  219:121. 2018
  • Lessons learned from domestic and international human papillomavirus vaccination programs: a review.  218:467-473. 2018
  • Fellow perceptions of residency training in obstetrics and gynecology.  218:461-462. 2018
  • SMFM Special Report: Putting the “M” back in MFM: Reducing racial and ethnic disparities in maternal morbidity and mortality: A call to action.  218:B9-B17. 2018
  • Defining failed induction of labor.  218:122.e1-122.e8. 2018
  • Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids.  218:130.e1-130.e13. 2018
  • Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.  218:111.e1-111.e9. 2018
  • Reply.  218:148. 2018
  • A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.  217:678.e1-678.e9. 2017
  • Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.  217:432.e1-432.e17. 2017
  • The effect of omega-3 supplementation on pregnancy outcomes by smoking status.  217:476.e1-476.e6. 2017
  • Population-attributable fraction of tubal factor infertility associated with chlamydia.  217:336.e1-336.e16. 2017
  • Predictors of vaginal delivery in medically indicated early preterm induction of labor.  217:375.e1-375.e7. 2017
  • Preemptive analgesia for postoperative hysterectomy pain control: systematic review and clinical practice guidelines.  217:303-313.e6. 2017
  • The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.  217:369.e1-369.e9. 2017
  • Maternal stress and neonatal anthropometry: the NICHD Fetal Growth Studies.  217:82.e1-82.e7. 2017
  • Group prenatal care.  216:552-556. 2017
  • Preventing human papillomavirus–related cancers: we are all in this together.  216:576.e1-576.e5. 2017
  • Validity of self-reported history of Chlamydia trachomatis infection.  216:393.e1-393.e7. 2017
  • Infant outcomes among women with Zika virus infection during pregnancy: results of a large prenatal Zika screening program.  216:292.e1-292.e8. 2017
  • Transitioning from HPV 101 to HPV 202.  216:206-207. 2017
  • Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence.  216:55.e1-55.e16. 2017
  • Facilitators and barriers to the use of standing orders for vaccination in obstetrics and gynecology settings.  216:69.e1-69.e7. 2017
  • Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women.  216:71.e1-71.e16. 2017
  • Dichorionic twin trajectories: the NICHD Fetal Growth Studies.  215:221.e1-221.e16. 2016
  • The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia..  215:217.e1-217.e5. 2016
  • Preterm neonatal morbidity and mortality by gestational age: A contemporary cohort.  215:103.e1-103.e14. 2016
  • Revisiting the cost-effectiveness of universal cervical length screening: Importance of progesterone efficacy.  215:101.e1-101.e7. 2016
  • Prenatal screening for fetal aneuploidy: Time to examine where we are and where we are going.  214:673-675. 2016
  • Effect of a multi-modal intervention on immunization rates in obstetrics and gynecology clinics.  214:617.e1-617.e7. 2016
  • Functional status in older women diagnosed with pelvic organ prolapse.  214:613.e1-613.e7. 2016
  • Cervical cancer screening: Evidence behind the guidelines.  214:438-443. 2016
  • Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth Presented in part as a poster presentation at the 35th Annual Society of Maternal Fetal Medicine Meeting, San Diego, CA, February 2-7, 2015..  214:376.e1-376.e8. 2016
  • Reply.  214:296-297. 2016
  • The use of quality metrics in health care: Primum non nocere and the law of unintended consequences.  214:143-144. 2016
  • #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.  214:6-14. 2016
  • Evaluating gestational weight gain recommendations in pregestational diabetes.  213:563.e1-563.e5. 2015
  • Racial/ethnic standards for fetal growth: The NICHD Fetal Growth Studies.  213:449.e1-449.e41. 2015
  • Serious maternal complications after early preterm delivery (24-33 weeks' gestation).  213. 2015
  • The female urinary microbiome in urgency urinary incontinence.  213. 2015
  • Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.  213:398.e1-398.e11. 2015
  • Survey of American obstetricians regarding group B streptococcus: Opinions and practice patterns.  213:229.e1-229.e7. 2015
  • The relationship between timing of postpartum hemorrhage interventions and adverse outcomes.  213:239.e1-239.e3. 2015
  • Does the presence of a condition-specific obstetric protocol lead to detectable improvements in pregnancy outcomes?.  213. 2015
  • Obesity and perioperative pulmonary complications in robotic gynecologic surgery.  213. 2015
  • Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis.  212:812.e1-812.e6. 2015
  • The GoMo study: A randomized clinical trial assessing neonatal pain with Gomco vs Mogen clamp circumcision.  212:664.e1-664.e8. 2015
  • The GoMo study: a randomized clinical trial assessing neonatal pain with Gomco vs Mogen clamp circumcision.  212. 2015
  • The phenotype of spontaneous preterm birth: Application of a clinical phenotyping tool.  212:487.e1-487.e11. 2015
  • #37: Diagnosis and management of vasa previa.  213:615-619. 2015
  • Nonmedically indicated induction vs expectant treatment in term nulliparous women.  212:103.e1-103.e7. 2015
  • Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: A systematic review.  212:145-156. 2015
  • Reply.  212:690-691. 2015
  • Review of multicenter studies by multiple institutional review boards: Characteristics and outcomes for perinatal studies implemented by a multicenter network.  212:110.e1-110.e6. 2015
  • The future of obstetrics/gynecology in 2020: A clearer vision. Transformational forces and thriving in the new system.  212:28-33.e1. 2015
  • Maternal serum serpin B7 is associated with early spontaneous preterm birth.  211:678.e1-678.e12. 2014
  • Mode of delivery in women with class III obesity: Planned cesarean compared with induction of labor.  211:700.e1-700.e9. 2014
  • The future of obstetrics/gynecology in 2020: A clearer vision: Finding true north and the forces of change.  211:617-622.e1. 2014
  • Effectiveness of blinding: Sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery.  211:554.e1-554.e7. 2014
  • Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence.  211:550.e1-550.e5. 2014
  • The future of obstetrics/gynecology in 2020: A clearer vision. Why is change needed?.  211:470-474.e1. 2014
  • The utility of ultrasound surveillance of fluid and growth in obese women.  211:524.e1-524.e8. 2014
  • Thyroid screening in pregnancy.  211:351-353.e1. 2014
  • Findings of universal cystoscopy at incontinence surgery and their sequelae.  210:480.e1-480.e8. 2014
  • A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.  211:68.e1-68.e8. 2014
  • Can differences in obstetric outcomes be explained by differences in the care provided? the MFMU Network APEX study.  211:147.e1-147.e16. 2014
  • Defining an abnormal first stage of labor based on maternal and neonatal outcomes.  210:536.e1-536.e7. 2014
  • Hyperglycemia impairs cytotrophoblast function via stress signaling.  211:541.e1-541.e8. 2014
  • Inadequate weight gain in overweight and obese pregnant women: What is the effect on fetal growth?.  211:137.e1-137.e7. 2014
  • Is total thyroxine better than free thyroxine during pregnancy?.  211:132.e1-132.e6. 2014
  • Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort.  210:226.e1-226.e7. 2014
  • Reply.  210:92-93. 2014
  • Urinary incontinence management costs are reduced following Burch or sling surgery for stress incontinence.  211:171.e1-171.e7. 2014
  • Reply.  209:396. 2013
  • Transvaginal cervical cerclage: Evidence for perioperative management strategies.  209:181-192. 2013
  • Putting the "m" back in maternal-fetal medicine.  208:442-448. 2013
  • Erratum: (American Journal of Obstetrics and Gynecology 208:1 (S93)).  208:407. 2013
  • Erratum: Maternal antidepressant use and adverse outcomes: A cohort study of 228,876 pregnancies (American Journal of Obstetrics and Gynecology (2012) 207 49 (e1-9)).  208:326. 2013
  • Adherence to criteria for transvaginal ultrasound imaging and measurement of cervical length.  209:365.e1-365.e5. 2013
  • Effect of corticosteroid interval on markers of inflammation in spontaneous preterm birth.  209:379.e1-379.e6. 2013
  • Human papillomavirus: What every provider should know.  208:169-175. 2013
  • Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.  209:244.e1-244.e9. 2013
  • Maternal seizure disorder and risk of adverse pregnancy outcomes.  208:378.e1-378.e5. 2013
  • Radiographic measures of the mid pelvis to predict cesarean delivery.  208:460.e1-460.e6. 2013
  • Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.  209:51.e1-51.e6. 2013
  • Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals.  209:446.e1-446.e30. 2013
  • Significance of growth discordance in appropriately grown twins.  208:393.e1-393.e5. 2013
  • The pelvic floor complication scale: A new instrument for reconstructive pelvic surgery.  208:81.e1-81.e9. 2013
  • The risks and benefits of internal monitors in laboring patients.  209:38.e1-38.e6. 2013
  • The role of the fallopian tube in the origin of ovarian cancer.  209:409-414. 2013
  • Moderate ambient level of carbon monoxide and risk of preeclampsia: Zhai et al.  207:78-79. 2012
  • 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.  207:390.e1-390.e8. 2012
  • Association of induction of labor and uterine rupture in women attempting vaginal birth after cesarean: A survival analysis.  206:51.e1-51.e5. 2012
  • Discussion: 'Moderate ambient level of carbon monoxide and risk of preeclampsia' by Zhai et al.  207:e6. 2012
  • Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus.  206:422.e1-422.e5. 2012
  • Gestational age at delivery and perinatal outcomes of twin gestations.  207:410.e1-410.e6. 2012
  • Maternal BMI, glucose tolerance, and adverse pregnancy outcomes.  207:62.e1-62.e7. 2012
  • Maternal antidepressant use and adverse outcomes: A cohort study of 228,876 pregnancies.  207:49.e1-49.e9. 2012
  • Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.  207:475.e1-475.e14. 2012
  • Pharmacologic treatment for urgency-predominant urinary incontinence in women diagnosed using a simplified algorithm: A randomized trial.  206:444.e1-444.e11. 2012
  • Risk of preterm delivery and growth restriction in twins discordant for structural anomalies.  206:70.e1-70.e5. 2012
  • The new American Journal of Obstetrics and Gynecology, 5 years later: Looking back and moving forward.  206:364-373. 2012
  • The pattern of labor preceding uterine rupture.  207:210.e1-210.e6. 2012
  • Timing of delivery and pregnancy outcomes among laboring nulliparous women.  206:239.e1-239.e8. 2012
  • Adhesion prevention in patients with multiple cesarean deliveries..  205:S19-S24. 2011
  • Placental dysfunction disorders across generations: Wikström et al.  205:506-507. 2011
  • Surgically managed stage I endometrial cancer in a low-volume center: outcomes and complications in a military residency program..  205:356.e1-356.e5. 2011
  • Bacterial vaginosis and STI risk: Allsworth et al.  205:158-159. 2011
  • Evaluation and management of adnexal mass in pregnancy.  205:97-102. 2011
  • Cervical conization and the risk of preterm delivery.  205:19-27. 2011
  • Making the best match: Can we select the right residents for obstetrics and gynecology and for our own programs?.  204:369-370. 2011
  • Adolescent pregnancy and gestational weight gain: Do the Institute of Medicine recommendations apply?.  205:140.e1-140.e8. 2011
  • Antithyroid antibodies and parity: Further evidence for microchimerism in autoimmune thyroid disease.  205:471.e1-471.e4. 2011
  • Discussion: 'Bacterial vaginosis and STI risk' by Allsworth et al.  205:e1. 2011
  • Discussion: 'Placental dysfunction disorders across generations' by Wikström et al.  205:e1. 2011
  • Does midtrimester Nugent score or high vaginal pH predict gestational age at delivery in women at risk for recurrent preterm birth?.  204:46.e1-46.e4. 2011
  • Maternal insulin resistance and preeclampsia.  204:327.e1-327.e6. 2011
  • Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.  204:342.e1-342.e5. 2011
  • Racial and regional differences in age at menopause in the United States: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  205:353.e1-353.e8. 2011
  • Tinidazole vs metronidazole for the treatment of bacterial vaginosis.  204:211.e1-211.e6. 2011
  • 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.  202:351.e1-351.e6. 2010
  • Cervical funneling: Effect on gestational length and ultrasound-indicated cerclage in high-risk women.  203:259.e1-259.e5. 2010
  • Co-expression of GPR30 and ERβ and their association with disease progression in uterine carcinosarcoma.  203:242.e1-242.e5. 2010
  • Correlation between levator ani muscle injuries on magnetic resonance imaging and fecal incontinence, pelvic organ prolapse, and urinary incontinence in primiparous women.  202:488.e1-488.e6. 2010
  • Discussion: 'Infant death among Ohio residents' by Donovan et al.  203:e8. 2010
  • Discussion: 'Vitamin D insufficiency in women of childbearing age' by Ginde et al.  202:e1. 2010
  • Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?.  203:393.e1-393.e5. 2010
  • Effect of placenta previa on fetal growth.  203:330.e1-330.e5. 2010
  • Gestational age at previous preterm birth does not affect cerclage efficacy.  203:377.e1-377.e4. 2010
  • Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.  202:297.e1-297.e8. 2010
  • Infant death among Ohio residents: Donovan et al.  203:86-87. 2010
  • Vitamin D insufficiency in women of childbearing age: Ginde et al.  202:509-510. 2010
  • Hot and blue Lymphoscintigraphy might be useful in cervical cancer surgery..  201:223.e1-223.e2. 2009
  • Associated factors and the impact of fecal incontinence in women with urge urinary incontinence: from the Urinary Incontinence Treatment Network's Behavior Enhances Drug Reduction of Incontinence study.  200:424.e1-424.e8. 2009
  • Progesterone for preterm birth prevention: an evolving intervention.  200:219-224. 2009
  • Abnormal fetal heart rate tracings in patients with thick meconium staining of the amniotic fluid: Xu et al.  200:342-343. 2009
  • Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study.  201:177.e1-177.e9. 2009
  • Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.  200:188.e1-188.e7. 2009
  • Discussion: 'Abnormal fetal heart rate tracings in patients with thick meconium staining of the amniotic fluid' by Xu et al.  200:e1. 2009
  • Effect of gestational age at the prior cesarean delivery on maternal morbidity in subsequent VBAC attempt.  200:276.e1-276.e6. 2009
  • Fecal incontinence in obese women with urinary incontinence: prevalence and role of dietary fiber intake.  200:566.e1-566.e6. 2009
  • Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length.  201:375.e1-375.e8. 2009
  • Novel clomiphene protocol in polycystic ovarian syndrome: Hurst et al.  200:586-587. 2009
  • Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.  200:457.e1-457.e5. 2009
  • To the point: reviews in medical education-the Objective Structured Clinical Examination.  200:25-34. 2009
  • Validation of serum biomarkers for detection of early-stage ovarian cancer.  200:639.e1-639.e5. 2009
  • 317: Umbilical cord gases and neuro-developmental disability in very preterm births.  199:S99-S99. 2008
  • To the point: medical education review of the role of simulators in surgical training.  199:338-343. 2008
  • Steering Committee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development's (NICHD) Maternal-Fetal Medicine Units Network.  199. 2008
  • A comprehensive review to establish priority learning objectives for medical students in the obstetrics and gynecology clerkship.  199:563.e1-563.e9. 2008
  • Chlamydial and gonococcal infections in women seeking pregnancy testing at family-planning clinics.  198:502.e1-502.e4. 2008
  • Delivery method and outcome in very low birthweight fetuses: Wylie et al.  198. 2008
  • Delivery method and outcome in very low birthweight fetuses: Wylie et al.  198:713-714. 2008
  • Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis.  198:287.e1-287.e6. 2008
  • Discussion: 'Physician gender, specialty, and hysterectomy utilization' by Gretz et al.  199:e1. 2008
  • Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?.  198:30.e1-30.e7. 2008
  • Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age.  198:466.e1-466.e11. 2008
  • Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection.  199:303.e1-303.e3. 2008
  • Intraabdominal pressure changes associated with lifting: implications for postoperative activity restrictions.  198:306.e1-306.e5. 2008
  • Obesity and outcomes after sacrocolpopexy.  199:690.e1-690.e8. 2008
  • Outcomes of combination treatment of fecal incontinence in women.  199:699.e1-699.e7. 2008
  • Physician gender, specialty, and hysterectomy utilization: Gretz et al.  199:438-439. 2008
  • The Alabama Preterm Birth Study: Umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.  198:43.e1-43.e5. 2008
  • The increasing racial disparity in infant mortality rates: Composition and contributors to recent US trends.  198:51.e1-51.e9. 2008
  • To the point: medical education review of the RIME method for the evaluation of medical student clinical performance.  197:123-133. 2007
  • The outcome of infants with an Apgar score of zero at 10 minutes: past and future.  196:422-423. 2007
  • A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.  196:517.e1-517.e6. 2007
  • ANGELS and University of Arkansas for Medical Sciences paradigm for distant obstetrical care delivery.  196:534.e1-534.e9. 2007
  • Bladder symptoms 1 year after abdominal sacrocolpopexy with and without Burch colposuspension in women without preoperative stress incontinence symptoms.  197:647.e1-647.e6. 2007
  • Bowel symptoms in women 1 year after sacrocolpopexy.  197:642.e1-642.e8. 2007
  • Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction.  197:367.e1-367.e6. 2007
  • Fetal loss and sickle cell trait: a valid association.  196. 2007
  • Impact of interconception antibiotics on the endometrial microbial flora.  196:226.e1-226.e6. 2007
  • Intrauterine device use in a high-risk population: experience from an urban university clinic.  197:193.e1-193.e7. 2007
  • Levator ani abnormality 6 weeks after delivery persists at 6 months.  197:65.e1-65.e6. 2007
  • Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery.  197:662.e1-662.e7. 2007
  • Race and ethnicity do not contribute to differences in preoperative urinary incontinence severity or symptom bother in women who undergo stress incontinence surgery.  197:92.e1-92.e6. 2007
  • Reply.  196. 2007
  • Risk factors for sonographic internal anal sphincter gaps 6-12 months after delivery complicated by anal sphincter tear.  197:310.e1-310.e5. 2007
  • Sexual function before and after sacrocolpopexy for pelvic organ prolapse.  197:629.e1-629.e6. 2007
  • Teaching and practicing of pelvic floor muscle exercises in primiparous women during pregnancy and the postpartum period.  197:107.e1-107.e5. 2007
  • The global network: a prospective study of stillbirths in developing countries.  197:247.e1-247.e5. 2007
  • The impact of fecal and urinary incontinence on quality of life 6 months after childbirth.  197:636.e1-636.e6. 2007
  • The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women.  197:488.e1-488.e5. 2007
  • Trends in neonatal morbidity and mortality for very low birthweight infants.  196:147.e1-147.e8. 2007
  • Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women.  195:1611-1616. 2006
  • Bowel symptoms in women planning surgery for pelvic organ prolapse.  195:1814-1819. 2006
  • Corticosteroids and HELLP.  195. 2006
  • Fetal growth risk curves: Defining levels of fetal growth restriction by neonatal death risk.  195:1571-1577. 2006
  • Placental transfer of rosiglitazone in the ex vivo human perfusion model.  195:1715-1719. 2006
  • Reply.  195. 2006
  • The Alabama Preterm Birth Study: Intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks.  195:1533-1537. 2006
  • The International Infections in Pregnancy (IIP) study: Variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women.  195:1198-1204. 2006
  • HPTN 024 study: Histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.  195:1065-1074. 2006
  • The Alabama Preterm Birth Study: Corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection.  195:1020-1024. 2006
  • The Alabama Preterm Birth Project: Placental histology in recurrent spontaneous and indicated preterm birth.  195:792-796. 2006
  • The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants.  195:803-808. 2006
  • Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery.  195:208-214. 2006
  • Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair.  194:1486-1491. 2006
  • Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.  194:1283-1289. 2006
  • Are women with recurrent spontaneous preterm births different from those without such history?.  194:1176-1184. 2006
  • To the Point: Reviews in medical education online computer assisted instruction materials.  194:1064-1069. 2006
  • Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.  194:774-781. 2006
  • Midpregnancy genitourinary tract infection with Chlamydia trachomatis: Association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis.  194:493-500. 2006
  • Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: Resource use in the Medicine or Surgery (Ms) trial.  194:332-338. 2006
  • The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort.  194:381-386. 2006
  • A randomized trial of coached versus uncoached maternal pushing during the second stage of labor.  194:10-13. 2006
  • Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial.  194:617-623. 2006
  • Environmental contaminants and maternal thyroid function.  193:1889-1890. 2005
  • Factors associated with incontinence frequency in a surgical cohort of stress incontinent women.  193:2088-2093. 2005
  • Racial differences in pelvic morphology among asymptomatic nulliparous women as seen on three-dimensional magnetic resonance images.  193:2035-2040. 2005
  • Regret, satisfaction, and symptom improvement: Analysis of the impact of partial colpocleisis for the management of severe pelvic organ prolapse.  193:2067-2070. 2005
  • Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial.  193:1630-1639. 2005
  • Reply.  193:1883-1883. 2005
  • The essential elements of undergraduate medical education in obstetrics and gynecology: A comparison of the Association of Professors of Gynecology and Obstetrics Medical Student Educational Objectives and the National Board of Medical Examiners Subject Examination.  193:1773-1779. 2005
  • Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy.  193:1478-1485. 2005
  • Do factors that are important during obstetrics and gynecology residency program selection differ by applicant gender?.  193:1540-1543. 2005
  • Endometrial microbial colonization and plasma cell endometritis after spontaneous or indicated preterm versus term delivery.  193:739-745. 2005
  • High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: A randomized trial.  193:1065-1070. 2005
  • The Maternal-Fetal Medicine Unit cesarean registry: Trial of labor with a twin gestation.  193:135-140. 2005
  • Pathologic uterine torsion associated with placental abruption, maternal shock, and intrauterine fetal demise.  192:2082-2083. 2005
  • A randomized trial of the effects of coached vs uncoached maternal pushing during the second stage of labor on postpartum pelvic floor structure and function.  192:1692-1696. 2005
  • Anal incontinence in women presenting for gynecologic care: Prevalence, risk factors, and impact upon quality of life.  192:1637-1642. 2005
  • Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes.  192:1162-1166. 2005
  • Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation?.  192:470-477. 2005
  • Obstetric antecedents for postpartum pelvic floor dysfunction.  192:1655-1662. 2005
  • To the point: Medical education reviews - Dealing with student difficulties in the clinical setting.  193:1915-1922. 2005
  • To the point: Medical education reviews evaluation in context: Assessing learners, teachers, and training programs.  192:34-37. 2005
  • WHI response to Ostrzenski and Ostrzenska.  193:1605-1606. 2005
  • The prevalence of androgen excess among patients with minimal unwanted hair growth.  191:1914-1920. 2004
  • To the point: Reviews in medical education teaching techniques.  191:408-411. 2004
  • Can shortened midtrimester cervical length predict very early spontaneous preterm birth?.  191:298-303. 2004
  • Number and gestational age of prior preterm births does not modify the predictive value of a short cervix.  191:241-246. 2004
  • Prophylactic progesterone to prevent preterm birth [3].  190:1799-1800. 2004
  • Reply.  190:1174-1174. 2004
  • An evaluation of trends in obstetrics and gynecology clerkships in the United States and Canada.  191:354-358. 2004
  • An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.  190:721-729. 2004
  • Assessing the impact of a comprehensive sexually transmitted disease curriculum on learning outcomes.  191:1822-1827. 2004
  • Cervicovaginal cytokines, vaginal infection, and preterm birth.  190:1179. 2004
  • Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus?.  190:775-778. 2004
  • Laparoscopic supracervical hysterectomy.  191:1875-1884. 2004
  • Optical detection of high-grade cervical intraepithelial neoplasia in vivo: Results of a 604-patient study.  190:1249-1257. 2004
  • Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.  190:737-744. 2004
  • Reproductive health history of lesbians: Implications for care.  190:1298-1304. 2004
  • Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment.  190:363-370. 2004
  • Clinical trial of chlorhexidine vaginal irrigation to prevent peripartal infection in nulliparous women.  189:166-170. 2003
  • Erratum: Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. (American Journal of Obstetrics and Gynecology (2002) 186 (422-426)).  189:244. 2003
  • Medroxyprogesterone acetate treatment of abnormal uterine bleeding: Factors predicting satisfaction.  189:37-42. 2003
  • Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women.  188. 2003
  • A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3.  188:1186-1188. 2003
  • Differing symptoms of abused versus nonabused women in obstetric-gynecology settings.  188:707-713. 2003
  • Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women.  188:831-835. 2003
  • Maternal and transplacental pharmacokinetics of azithromycin.  188:714-718. 2003
  • Vaginal sonography and cervical incompetence.  188:586-596. 2003
  • Burden of stress urinary incontinence for community-dwelling women.  189:1275-1282. 2003
  • Cadaveric fascia lata sling for stress urinary incontinence: A prospective quality-of-life analysis.  189:1590-1595. 2003
  • It's time to challenge surgical dogma with evidence-based data..  189:423-427. 2003
  • Adolescents' ambivalence about becoming pregnant predicts infrequent contraceptive use: A prospective analysis of nonpregnant African American females.  186:251-252. 2002
  • Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.  186:66-71. 2002
  • Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas.  186:422-426. 2002
  • Risk factors associated with anal sphincter tear: A comparison of primiparous patients, vaginal births after cesarean deliveries, and patients with previous vaginal delivery.  187:1194-1198. 2002
  • Severe preeclampsia at <25 weeks of gestation: Maternal and neonatal outcomes.  186:790-795. 2002
  • The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  184:483-488. 2001
  • Can prenatal ultrasound findings predict ambulatory status in fetuses with open spina bifida?.  185:1016-1020. 2001
  • Cesarean delivery rate among women with severe hypertensive disease - Possible reduction with epidural anesthesia? [1] (multiple letters).  184:514. 2001
  • Effects of pubovaginal sling procedure on patients with urethral hypermobility and intrinsic sphincteric deficiency: Would they do it again?.  184:14-19. 2001
  • Lack of utility of amniotic fluid index in predicting perinatal morbidity and mortality [4] (multiple letters).  184:778-779. 2001
  • Laminaria versus extra-amniotic saline solution infusion for cervical ripening in second-trimester labor inductions.  184:1145-1148. 2001
  • Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.  185:163-165. 2001
  • Nutrient intake and hypertensive disorders of pregnancy: Evidence from a large prospective cohort.  184:643-651. 2001
  • Outcomes among term infants when two-hour postnatal pH is compared with pH at delivery.  184:447-450. 2001
  • The effect of the increasing prevalence of maternal obesity on perinatal morbidity.  185:845-849. 2001
  • The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.  184:1204-1210. 2001
  • The preterm prediction study: Association between cervical interleukin 6 concentration and spontaneous preterm birth.  184:483-488. 2001
  • The preterm prediction study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  182:631-635. 2000
  • The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  182:625-630. 2000
  • Asymptomatic bacterial vaginosis: Response to therapy.  183:1434-1439. 2000
  • Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy.  183:1100-1102. 2000
  • Epidural anesthesia in severe preeclampsia [3] (multiple letters).  183:258. 2000
  • Erratum: Mid-trimester vaginal biological markers of infection predictive of lower genital tract fetal fibronectin (FFN) (American Journal of Obstetrics and Gynecology (2000) 182 (1-2)).  182:751. 2000
  • Genital human papillomavirus infection in women who have sex with women: A review.  183:770-774. 2000
  • Hidden costs of infertility treatment in employee health benefits plans.  182:891-895. 2000
  • Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model.  182:553-559. 2000
  • Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks' gestation.  182:909-912. 2000
  • Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies.  183:1520-1524. 2000
  • Puerperal infection after cesarean delivery: Evaluation of a standardized protocol.  182:1147-1151. 2000
  • Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus.  182:364-369. 2000
  • The Preterm Prediction Study: Cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth.  182:631-635. 2000
  • The Preterm Prediction Study: Granulocyte colony-stimulating factor and spontaneous preterm birth.  182:625-630. 2000
  • The preterm prediction study: Association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth.  183:662-668. 2000
  • The preterm prediction study: Quantitative fetal fibronectin values and the prediction of spontaneous preterm birth.  183:1480-1483. 2000
  • What is the meaning of authorship? [1] (multiple letters).  183:775-776. 2000
  • A five-year experience with fragile X screening of high-risk gravid women.  181:789-792. 1999
  • Benefits of maternal corticosteroid therapy in infants weighing <1000 grams at birth after preterm rupture of the amnion.  180:677-682. 1999
  • Indicated versus spontaneous preterm delivery: An evaluation of neonatal morbidity among infants weighing ≤1000 grams at birth.  180:683-689. 1999
  • Obstetric determinants of neonatal survival: Antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants.  180:665-669. 1999
  • Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography - A Faustian bargain?.  181:332-338. 1999
  • Prospective evaluation of free β-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.  181:887-892. 1999
  • Terbutaline [1] (multiple letters).  180:1593-1595. 1999
  • The Preterm Prediction Study: Failure of midtrimester cervical sialidase level elevation to predict subsequent spontaneous preterm birth.  180:1151-1154. 1999
  • The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease.  181:940-944. 1999
  • Transperineal versus endovaginal ultrasonographic examination of the cervix in the midtrimester: A blinded comparison.  181:780-783. 1999
  • Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery.  178:546-550. 1998
  • Maternal serum α-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.  179:966-970. 1998
  • Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.  179:846-851. 1998
  • Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.  179:758-761. 1998
  • Routine maternal platelet count: An assessment of a technologically driven screening practice.  179:573-576. 1998
  • Use of antibiotics to prevent preterm birth [2] (multiple letters).  178:624-625. 1998
  • Chlorhexidine vaginal irrigation for the prevention of peripartal infection: A placebo-controlled randomized clinical trial.  176:617-622. 1997
  • Electronic fetal heart rate monitoring: Research guidelines for interpretation.  177:1385-1390. 1997
  • Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.  177:992-996. 1997
  • Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial.  177:13-18. 1997
  • Management options in women with preterm uterine contractions: A randomized clinical trial.  177:814-818. 1997
  • Maternal serum human chorionic gonadotropin level at 15 weeks.  176:258. 1997
  • Maternal serum human chorionic gonadotropin level at 15 weeks..  176:258. 1997
  • Obstetric determinants of neonatal survival: Influence of willingness to perform cesarean delivery on survival of extremely low-birth-weight infants.  176:960-966. 1997
  • Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis.  177:831-834. 1997
  • The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix.  177:133-138. 1997
  • The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery.  177:8-12. 1997
  • α-fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.  177:987-991. 1997
  • The feasibility of a randomized clinical perinatal trial: Maternal magnesium sulfate for the prevention of cerebral palsy.  175:701-705. 1996
  • On the use of surrogate end points for the calculation of the false- positive rate of antenatal testing [10].  175:756-757. 1996
  • Bacterial colonization of the vagina during pregnancy in four ethnic groups.  174:1618-1621. 1996
  • Complications of midtrimester pregnancy termination: The effect of prior cesarean delivery.  175:889-892. 1996
  • Dynamics of the fetal adrenal, cholesterol, and apolipoprotein B responses to antenatal betamethasone therapy.  174:562-565. 1996
  • Effect of parity correction on Down syndrome detection by the multiple- marker screening test.  175:1004-1007. 1996
  • Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss.  175:830-833. 1996
  • The preterm prediction study: Maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation.  175:1286-1292. 1996
  • Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women..  172:1251-1256. 1995
  • Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth..  172:666-671. 1995
  • Amniotic fluid interleukin-6: Correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery.  173:606-612. 1995
  • Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birth.  172:666-671. 1995
  • Comparion of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥35 years old.  173:1287-1292. 1995
  • Determinants of the optimal time in gestation to initiate antenatal fetal testing: A decision-analytic approach.  173:1357-1363. 1995
  • Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension?.  173:1219-1222. 1995
  • Effects of sacrocolposuspension on the lower urinary tract.  173:1684-1689. 1995
  • Gestational diabetes survey.  172:615-620. 1995
  • Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia.  173:687-694. 1995
  • Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants.  173:299-305. 1995
  • Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.  173:578-584. 1995
  • Practice variation in the use of corticosteroids: A comparison of eight data sets.  173:296-298. 1995
  • Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor.  173:1310-1315. 1995
  • The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels.  173:1292-1296. 1995
  • The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome.  173:1297-1300. 1995
  • The preterm prediction study: Significance of vaginal infections.  173:1231-1235. 1995
  • The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group..  170:869-873. 1994
  • Acid-base status at birth and subsequent neurosensory impairment in surviving 500 to 1000 gm infants.  170:48-53. 1994
  • Comparison of perceived and actual rates of survival and freedom from handicap in premature infants.  171:432-439. 1994
  • Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.  171:1038-1041. 1994
  • Oral Concurrent Session A Maternal Fetal Physiology.  170:268-270. 1994
  • Prediction of preterm birth in nulliparous patients.  171:1111-1115. 1994
  • The effect of corticosteroid therapy in the very premature infant.  170:869-873. 1994
  • The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome.  171:1041-1046. 1994
  • Urinary complaints after modified Burch urethropexy: An analysis.  171:1460-1464. 1994
  • Reply.  169:435. 1993
  • A multicenter study of preterm birth weight and gestational age-specific neonatal mortality..  168:78-84. 1993
  • A multicenter study of preterm birth weight and gestational age—specific neonatal mortality.  168:78-84. 1993
  • Are pill counts valid measures of compliance in clinical obstetric trials?.  169:1181-1182. 1993
  • Association of low maternal serum α-fetoprotein levels and intrauterine growth retardation [5].  169:435. 1993
  • Effects of intrapartum stress on fetal adrenal function.  169:1407-1411. 1993
  • Low-dose aspirin therapy to prevent preeclampsia.  168:1083-1093. 1993
  • Maternal risk factors and their influence on fetal anthropometric measurements.  168:1197-1205. 1993
  • Midpregnancy serum thromboxane B2 determinations do not predict subsequent adverse pregnancy outcomes.  169:105-106. 1993
  • Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture.  169:976-981. 1993
  • The effect of low-dose aspirin on fetal urine output and amniotic fluid volume.  169:885-888. 1993
  • The effect of low-dose aspirin on umbilical artery Doppler measurements.  169:907-911. 1993
  • Trial of labor after a one- or two-layer closure of a low transverse uterine incision.  168:545-546. 1993
  • Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group..  167:873-879. 1992
  • Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation.  167:596-601. 1992
  • Hemorrhagic endovasculitis of the placenta and fetomaternal hemorrhage: A relationship?.  167:860. 1992
  • Midtrimester pregnancy termination: A randomized trial of prostaglandin E2 versus concentrated oxytocin.  167:1112-1116. 1992
  • Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis.  167:873-879. 1992
  • Transverse uterine incision closure: One versus two layers.  167:1108-1111. 1992
  • A case report of giant cell arteritis of the uterus and adnexa.  164:540-542. 1991
  • Drug abuse screening of childbearing-age women in Alabama public health clinics.  165:924-927. 1991
  • Neonatal complications at term as related to the degree of umbilical artery acidemia.  164:637-641. 1991
  • Oligohydramnios: Antepartum fetal urine production and intrapartum fetal distress.  165:1077-1080. 1991
  • Reply.  164:236. 1991
  • Was there really a difference with amnioinfusion? (Reply).  164:236. 1991
  • A comparison between umbilical artery velocimetry and standard antepartum surveillance in hospitalized high-risk patients.  162:710-714. 1990
  • A prospective randomized study of saline solution amnioinfusion.  162:1146-1149. 1990
  • Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population.  163:873-879. 1990
  • Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population.  162:213-218. 1990
  • Intrauterine growth retardation is not the same as small for gestational age (I: Reply).  162:1643. 1990
  • Is indicated or spontaneous preterm delivery more advantageous for the fetus?.  163:868-872. 1990
  • Magnesium tocolysis: Serum levels versus success.  162:1177-1180. 1990
  • Reply.  162:1643. 1990
  • Retropubic long-needle suspension procedures for stress urinary incontinence.  163:551-557. 1990
  • Smoking, maternal age, fetal growth, and gestational age at delivery.  162:53-58. 1990
  • Study of preterm birth draws different interpretation.  162:1626-1627. 1990
  • The relationship between maternal serum and amniotic fluid α-fetoprotein in women undergoing early amniocentesis.  163:903-906. 1990
  • Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery.  162:748-754. 1990
  • Compensatory ovarian hypertrophy occurs by a mechanism distinct from compensatory growth in the regenerating liver..  161:1653-1657. 1989
  • A comparison of perinatal outcome in patients undergoing contraction stress testing performed by nipple stimulation versus spontaneously occurring contractions.  160:1081-1085. 1989
  • Comparison of predelivery versus postdelivery Kleihauer-Betke stains in cases of fetal death.  161:663-666. 1989
  • Compensatory ovarian hypertrophy occurs by a mechanism distinct from compensatory growth in the regenerating liver.  161:1653-1657. 1989
  • Endocrine maturation and lung function in premature neonates of women with diabetes.  160:657-662. 1989
  • Identification of a deoxyribonucleic acid allelic variant for β1-4 galactosyltransferase expression associated with male sperm binding/penetration infertility.  160:1160-1165. 1989
  • Indomethacin-induced oligohydramnios.  160:1196-1197. 1989
  • Intrauterine growth retardation: Standards for diagnosis.  161:271-277. 1989
  • Polyarteritis nodosa in pregnancy: A case report and brief literature review.  160:606-607. 1989
  • Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational age.  160:462-470. 1989
  • Prolactin levels in umbilical cord blood of human infants: Relation to gestational age, maternal complications, and neonatal lung function.  161:795-802. 1989
  • The effects of syphilis on endocrine function of the fetoplacental unit..  159:1327-1331. 1988
  • Effects of ritodrine hydrochloride on arteriovenous blood gas and shunt in healthy pregnant yellow baboons.  158:658-663. 1988
  • Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil.  158:1169-1170. 1988
  • Adenosquamous carcinoma of the fallopian tube. A clinicopathologic case report with verification of the diagnosis by immunohistochemical and ultrastructural studies..  157:903-905. 1987
  • Adenosquamous carcinoma of the fallopian tube: A clinicopathologic case report with verification of the diagnosis by immunohistochemical and ultrastructural studies.  157:903-905. 1987
  • Amniotic fluid α-fetorotein levels and pregnancy outcome.  157:822-825. 1987
  • Inhibition of prolactin secretion by antiserum to the α- and β-subunits of gonadotropin.  156:863-868. 1987
  • The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy.  157:156-160. 1987
  • Advanced abdominal pregnancy associated with fetal pulmonary hypoplasia: Report of a case.  155:396-397. 1986
  • Cefotetan versus cefoxitin as prophylaxis in hysterectomy.  154:960-963. 1986
  • The role of biofeedback in Kegel exercise training for stress urinary incontinence.  154:58-64. 1986
  • Examination of data base in midforceps delivery study.  153:814. 1985
  • Decreased levels of amniotic fluid α-fetoprotein associated with Down syndrome.  153:541-544. 1985
  • Reply.  153:594-595. 1985
  • Low birth weight, intrauterine growth retardation, and preterm delivery.  152:980-984. 1985
  • Application of Doppler echocardiography in the assessment of fetal cardiac disease.  151:951-957. 1985
  • Fatal meconium aspiration syndrome occurring despite airway management considered appropriate.  151:731-736. 1985
  • Umbilical cord pH, Pco2, and bicarbonate following uncomplicated term vaginal deliveries.  151:798-800. 1985
  • Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survival.  151:608-611. 1985
  • Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device.  150:998-999. 1984
  • Characteristics, mortality, and outcome of higher-birth weight infants who require intensive care.  149:875-879. 1984
  • Survival of infants with low birth weight and early gestational age, 1979 to 1981.  149:508-511. 1984
  • Reply to Campbell et al.  149:241-242. 1984
  • Second-stage fetal tachycardia and neonatal infection.  148:779-781. 1984
  • The use of real-time ultrasound as an aid during difficult therapeutic abortion procedures.  148:826-827. 1984
  • Transient fetal anuria of unknown etiology: A case report.  149:87. 1984
  • Umbilical cord pH and PCO2: Effect of interval from delivery to determination.  148:191-194. 1984
  • Ritodrine hydrochloride infusion in pregnant baboons. II. Sodium and water compartment alterations.  147:254-259. 1983
  • In caul delivery of the very premature Infant.  145:645-646. 1983
  • Ritodrine hydrochloride infusion in pregnant baboons. I. Biophysical effects.  146:916-924. 1983
  • The effect of 17 α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.  146:187-190. 1983
  • Hypofibrinogenemia as a cause of delayed postpartum hemorrhage.  143:230-231. 1982
  • Fetal heart rate reactivity before and after maternal jogging during the third trimester.  142:545-547. 1982
  • Reply to Dr. Semchyshyn.  139:235-237. 1981
  • Appraisal of "rigid" blood glucose control during pregnancy in the overtly diabetic woman.  135:853-862. 1979
  • Reply to Dr. Kumarasamy.  135:549-550. 1979
  • Desoxycorticosterone in normal pregnancy. II. Cortisol-dependent fluctuations in free plasma desoxycorticosterone.  133:644-648. 1979
  • False negative oxytocin challenge test associated with abdominal pregnancy.  133:108-110. 1979
  • Desoxycorticosterone in normal pregnancy. I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol.  132:414-420. 1978
  • Oral prostaglandin E2 for labor induction in high-risk pregnancy.  125:881-888. 1976
  • International Standard Serial Number (issn)

  • 0002-9378
  • Electronic International Standard Serial Number (eissn)

  • 1097-6868